Cargando…

Fecal host biomarkers predicting severity of Clostridioides difficile infection

Clostridioides difficile is a major cause of health care–associated diarrhea. Severity ranges from mild to life-threatening, but this variability remains poorly understood. Microbiologic diagnosis of C. difficile infection (CDI) is straightforward but offers little insight into the patient’s prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golizeh, Makan, Winter, Kaitlin, Roussel, Lucie, Landekic, Marija, Langelier, Mélanie, Loo, Vivian G., Ndao, Momar, Vinh, Donald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821589/ https://www.ncbi.nlm.nih.gov/pubmed/33232301 http://dx.doi.org/10.1172/jci.insight.142976

Ejemplares similares

Loss of human ICOSL results in combined immunodeficiency
por: Roussel, Lucie, et al.
Publicado: (2018)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging
por: Golizeh, Makan, et al.
Publicado: (2018)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile
por: Suarez-Carantoña, Cecilia, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

The value of fecal calprotectin in Clostridioides difficile infection: A systematic review
por: Wen, Bao-Jiang, et al.
Publicado: (2022)

New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice
por: Golizeh, Makan, et al.
Publicado: (2022)

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
por: Meighani, Alireza, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection
por: Cho, Young-Seok
Publicado: (2021)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
por: Yoon, Hyuk, et al.
Publicado: (2021)

Clinical Characteristics and Fecal Microbiome in Recurrent Versus Nonrecurrent Clostridioides difficile Infection
por: Lanjewar, Swapnil, et al.
Publicado: (2021)

Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation
por: Kang, Seok Hyung, et al.
Publicado: (2023)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

An intact S-layer is advantageous to Clostridioides difficile within the host
por: Ormsby, Michael J., et al.
Publicado: (2023)

Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008–2015
por: Zanichelli, Veronica, et al.
Publicado: (2020)

Trypanosoma cruzi Infection and Host Lipid Metabolism
por: Miao, Qianqian, et al.
Publicado: (2014)

Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples
por: van Rossen, Tessel M., et al.
Publicado: (2021)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Pragmatic Strategy for Fecal Specimen Storage and the Corresponding Test Methods for Clostridioides difficile Diagnosis
por: Nho, Seong Won, et al.
Publicado: (2021)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation
por: Bachour, Salam P., et al.
Publicado: (2023)

New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection
por: Andersson, Jourdan A., et al.
Publicado: (2020)

Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview
por: Loureiro, Andréa V., et al.
Publicado: (2022)

Functional profile of host microbiome indicates Clostridioides difficile infection
por: Nzabarushimana, Etienne, et al.
Publicado: (2022)

Clostridioides difficile infection: traversing host–pathogen interactions in the gut
por: Cheng, Jeffrey K. J., et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile infections, France, 2010 to 2017
por: Colomb-Cotinat, Mélanie, et al.
Publicado: (2019)

Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay
por: Schweitzer, Lorne, et al.
Publicado: (2021)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic Clostridioides difficile Colonization and Infection
por: Han, Sung-Hee, et al.
Publicado: (2020)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Ulcerative Proctitis in a Patient With a History of Fecal Microbiota Transplant for Clostridioides difficile Infection
por: Massaro, Michael, et al.
Publicado: (2020)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
por: Ali, Hiba, et al.
Publicado: (2021)

Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis
por: Song, Yi Nong, et al.
Publicado: (2021)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6oe8gvvcjrp75trrttctnemuj5